It's all a bit of a sheet sandwich really, no one wants to approve its one technology, no one wants to lead the company, no one wants to partner with it = dead in the water.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025